type here...

CATEGORIES

Breaking Research

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

James Coyne -
Readers, including even experts, are falling for a hard sell job by venture capitalists who launder their funding of the study through a nonprofit foundation and seek not legalization

Covid: Why You Need a Booster

Michael Hunter, MD -
THE BAD NEWS? ALL THREE of the COVID-19 vaccines approved in the United States seem to be significantly less protective against the new Omicron variant...

Research on Controlling Cellular Outposts of the Immune System

Medika Life -
New RNA research. The miR-424(322)/503 gene cluster regulates pro- vs anti-inflammatory skin DC subset differentiation by modulating TGF-beta signaling

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories